TABLE 3.
Conclusion | ||||||
---|---|---|---|---|---|---|
Intervention | Substance | Population, sex | Measurement | Author/year/location | Clinical outcome | Skin physiological measurements |
NMF analysis |
60% aq. n‐propanol 0,5% aq. SLS |
25 (16F, 9M) healthy | D Squame | Angelova‐Fischer et al/ 2016/Netherlands 31 |
Reduction of NMF levels −55.4% with n‐propanol and −79.2% Pretreatment with occlusion −60.8% and −87.4%, respectively |
|
Patch test |
0,5% SLS 0,15% sodium hydroxide 60% n‐propanol 2,0% acetic acid |
8 (5F, 3M) healthy |
Tewameter Chromameter Corneometer D Squame AFM (atomic force microscopy) DTI (dermal texture index) |
Soltanipoor et al/ 2017/Netherlands, Germany, Denmark 45 |
55% reduction of NMF levels with n‐propanol, but as high as 75% with repeated exposure of SLS Changes in corneocyte topography with n‐propanol, SLS and NaOH after 96 hours with increase in DTI and circular nano objects |
n‐propanol caused only slight changes in TEWL and erythema, but a significant decrease in skin capacitance after 96 hours |
Keratinocyte culture |
0%, 0,1%, 0,5%, 1%, 2% – 10% increments of 70% w/w alcohol (ethanol, n‐propanol, isopropanol) IL‐1a DuoSet ELISA development kit and TNF‐a DuoSet development kit |
MTT assay | Cartner et al/2016/USA,UK 26 |
Marked cellular toxicity and significant TNF‐α and IL‐ 1α release by the skin residential cell with n‐propanol, followed by isopropanol and ethanol |
||
Occlusion‐modified tandem repeated irritation test | n‐propanol (30%, 45%, 60%, 75% aq.) |
20 (16F, 4M) healthy 20 (17F, 3M) atopic dermatitis |
D‐SQUAME (NMF analysis) | Angelova‐Fischer et al/ 2019/Germany, Austria, Netherland, Croatia 44 | Cumulative exposure to n‐propanol reduced significantly the NMF levels in healthy and atopic skin equally |
Note: ELISA, enzyme‐linked immunosorbent assay; F, female; M, male; MTT assay, cell viability assay; NMF, natural moisturizing factor; SLS, sodium lauryl sulfate.